Hyma Polimera, MD

Penn State Cancer Institute
Hershey, PA

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 3265 - PSMA-PET Radiopharmaceutical Image Scoring Method (PRISM): A Practical Tool for Predicting ¹⁷⁷lu-PSMA-617 Therapy Outcomes in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  Tuesday, October 1, 2024
  2:30 PM – 3:45 PM ET